Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease. [PDF]
Gozzo L +17 more
europepmc +1 more source
Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe: a scoping review. [PDF]
Aljadeeah S +5 more
europepmc +1 more source
Access to medicines for the treatment of chronic diseases in Chile: qualitative analysis of perceived patient barriers and facilitators in five regions of the country. [PDF]
Castillo-Laborde C +3 more
europepmc +1 more source
How does the medicines retail sector ensure continued access to medicines during public health emergencies? Lessons from the COVID-19 pandemic in Uganda. [PDF]
Hutchinson E +7 more
europepmc +1 more source
Facilitators, Barriers, and Potential Impacts of Implementation of e-Pharmacy in India and its Potential Impact on Cost, Quality, and Access to Medicines: Scoping Review. [PDF]
Apte A +4 more
europepmc +1 more source
Preparedness is key in the face of avian influenza uncertainty
Abdullahi Tunde Aborode +3 more
doaj +1 more source
Broken Promises: Racism and Access to Medicines in Canada. [PDF]
Moscou K +4 more
europepmc +1 more source
Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review. [PDF]
Sorato MM, Davari M, Kebriaeezadeh A.
europepmc +1 more source
Access to Essential Medicines in African Countries: An Introduction [PDF]
Danchin, Peter G, Hoffmann, Diane
core

